In BIOVEXO (2020–2025), DOMCA contributed to integrated pest management strategies targeting Xylella fastidiosa and its insect vector in olive cultivation.
DOMCA SA
Spanish biotech SME developing natural biopesticides and antimicrobial products for olive crop protection and aquaculture feed.
Their core work
DOMCA SA is a Spanish biotech SME specializing in natural antimicrobial and biocontrol products for agriculture and aquaculture. They develop bio-based solutions that replace or reduce synthetic pesticides and chemicals — products derived from natural compounds that act against bacterial pathogens, pests, and vectors. In BIOVEXO, their primary H2020 engagement, they contributed to field trials and mode-of-action research for controlling Xylella fastidiosa, the devastating bacterial disease threatening European olive groves. Their earlier work on aquaculture feed additives (AQUAGARLIC) shows a broader capability in natural antimicrobial formulations applicable across food production chains.
What they specialise in
Both AQUAGARLIC (aquaculture feed additive) and BIOVEXO (biopesticides) center on bio-based compounds with antimicrobial or pathogen-suppression properties.
AQUAGARLIC (2019–2020) was an SME Instrument Phase 1 project they coordinated, developing a dual-action antimicrobial and immunomodulatory feed product for fish farming.
BIOVEXO targets olive agroecosystems with field-tested biocontrol approaches, positioning DOMCA within the growing market for sustainable, residue-free crop protection.
How they've shifted over time
DOMCA entered H2020 funding with a self-initiated SME Instrument project (AQUAGARLIC) focused on aquaculture — a feed additive combining antimicrobial and immune-boosting properties for fish. By 2020, their focus shifted decisively toward crop protection, specifically the biocontrol of Xylella fastidiosa in olives, with keywords like "biopesticides", "vector", "mode-of-action", and "field trials" dominating their profile. This suggests the company is moving from niche aquaculture products toward the larger and more urgent agricultural biocontrol market, likely driven by Xylella's catastrophic spread across southern European olive regions.
DOMCA appears to be deepening its position in agricultural biocontrol — particularly for high-value Mediterranean crops under phytosanitary threat — which aligns with strong EU regulatory and market pressure to replace synthetic pesticides.
How they like to work
DOMCA has both led (AQUAGARLIC, as coordinator under SME Instrument Phase 1) and joined larger consortia (BIOVEXO, as participant in a multi-partner Innovation Action). With only 11 unique partners across two projects, their network is small but diversified across five countries, suggesting selective rather than broad partnership. Their willingness to coordinate a project signals capacity for project management, not just technical delivery.
DOMCA has worked with 11 consortium partners across 5 countries through two H2020 projects. Their network appears centered on Mediterranean agricultural research institutions and agri-biotech companies, consistent with the olive and food safety focus of their recent work.
What sets them apart
DOMCA occupies a rare niche as a southern Spanish SME with hands-on formulation and field-trial expertise in both aquaculture and crop biocontrol — two sectors that share an underlying competence in natural antimicrobial compounds. Their direct involvement in Xylella biocontrol research gives them early-mover visibility in one of the EU's highest-priority plant health challenges. For a consortium targeting Mediterranean agriculture or sustainable food production, DOMCA brings product development experience that most research institutes cannot offer.
Highlights from their portfolio
- BIOVEXOThe largest of their two projects (€563,021 EC funding, running to 2025), targeting Xylella fastidiosa — the bacterial pathogen that has destroyed millions of olive trees in Italy and threatens Spain — making this one of the most consequential plant disease projects in southern Europe.
- AQUAGARLICDOMCA's only coordinator role — a self-funded SME Instrument Phase 1 feasibility study demonstrating their ability to originate and lead an EU project around a proprietary natural feed additive concept.